BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 36434360)

  • 1. Tumour-derived exosomal lncRNA SNHG16 induces telocytes to promote metastasis of hepatocellular carcinoma via the miR-942-3p/MMP9 axis.
    Xu Y; Luan G; Li Z; Liu Z; Qin G; Chu Y
    Cell Oncol (Dordr); 2023 Apr; 46(2):251-264. PubMed ID: 36434360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomal lncRNA H19 promotes the progression of hepatocellular carcinoma treated with Propofol via miR-520a-3p/LIMK1 axis.
    Wang D; Xing N; Yang T; Liu J; Zhao H; He J; Ai Y; Yang J
    Cancer Med; 2020 Oct; 9(19):7218-7230. PubMed ID: 32767662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-124-3p availability is antagonized by LncRNA-MALAT1 for Slug-induced tumor metastasis in hepatocellular carcinoma.
    Cui RJ; Fan JL; Lin YC; Pan YJ; Liu C; Wan JH; Wang W; Jiang ZY; Zheng XL; Tang JB; Yu XG
    Cancer Med; 2019 Oct; 8(14):6358-6369. PubMed ID: 31466138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HOXA-AS2 Promotes Proliferation and Induces Epithelial-Mesenchymal Transition via the miR-520c-3p/GPC3 Axis in Hepatocellular Carcinoma.
    Zhang Y; Xu J; Zhang S; An J; Zhang J; Huang J; Jin Y
    Cell Physiol Biochem; 2018; 50(6):2124-2138. PubMed ID: 30415263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acidic Microenvironment Up-Regulates Exosomal miR-21 and miR-10b in Early-Stage Hepatocellular Carcinoma to Promote Cancer Cell Proliferation and Metastasis.
    Tian XP; Wang CY; Jin XH; Li M; Wang FW; Huang WJ; Yun JP; Xu RH; Cai QQ; Xie D
    Theranostics; 2019; 9(7):1965-1979. PubMed ID: 31037150
    [No Abstract]   [Full Text] [Related]  

  • 6. Long noncoding RNA 02027 inhibits proliferation, migration and invasion of hepatocellular carcinoma via miR-625-3p/PDLIM5 pathway.
    Wang J; Zhu Y; Ai X; Wan H; Jia W; Chu J; Xu B; Kong X; Kong L
    J Gene Med; 2023 Jun; 25(6):e3485. PubMed ID: 36811210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. lncRNA TUG1-Mediated Mir-142-3p Downregulation Contributes to Metastasis and the Epithelial-to-Mesenchymal Transition of Hepatocellular Carcinoma by Targeting ZEB1.
    He C; Liu Z; Jin L; Zhang F; Peng X; Xiao Y; Wang X; Lyu Q; Cai X
    Cell Physiol Biochem; 2018; 48(5):1928-1941. PubMed ID: 30092578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA TCTN2 Promotes the Malignant Development of Hepatocellular Carcinoma
    Liu Q; Zhu C; Dong Y
    Recent Pat Anticancer Drug Discov; 2023; 18(4):517-527. PubMed ID: 36278455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SNHG16/miR-605-3p/TRAF6/NF-κB feedback loop regulates hepatocellular carcinoma metastasis.
    Hu YL; Feng Y; Chen YY; Liu JZ; Su Y; Li P; Huang H; Mao QS; Xue WJ
    J Cell Mol Med; 2020 Jul; 24(13):7637-7651. PubMed ID: 32436333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosomal LINC00161 promotes angiogenesis and metastasis via regulating miR-590-3p/ROCK axis in hepatocellular carcinoma.
    You LN; Tai QW; Xu L; Hao Y; Guo WJ; Zhang Q; Tong Q; Zhang H; Huang WK
    Cancer Gene Ther; 2021 Jun; 28(6):719-736. PubMed ID: 33414518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Jianpi Huayu decoction inhibits the epithelial-mesenchymal transition of hepatocellular carcinoma cells by suppressing exosomal miR-23a-3p/Smad signaling.
    Xie CF; Feng KL; Wang JN; Luo R; Fang CK; Zhang Y; Shen CP; Zhong C
    J Ethnopharmacol; 2022 Aug; 294():115360. PubMed ID: 35568116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA BACE1-AS enhances the invasive and metastatic capacity of hepatocellular carcinoma cells through mediating miR-377-3p/CELF1 axis.
    Liu C; Wang H; Tang L; Huang H; Xu M; Lin Y; Zhou L; Ho L; Lu J; Ai X
    Life Sci; 2021 Jun; 275():119288. PubMed ID: 33667514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of lncRNA LINC01194 in hepatocellular carcinoma via the miR-655-3p/SMAD family member 5 axis.
    Liu Y; Liu J; Cui J; Zhong R; Sun G
    Bioengineered; 2022 Jan; 13(1):1115-1125. PubMed ID: 34978464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-128-3p suppresses tumor proliferation and metastasis via targeting CDC6 in hepatocellular carcinoma cells.
    Shi Y; Yan F; Wang F; Pan L
    Tissue Cell; 2021 Oct; 72():101534. PubMed ID: 33991762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HnRNPU-AS1 inhibits the proliferation, migration and invasion of HCC cells and induces autophagy through miR-556-3p/ miR-580-3p/SOCS6 axis.
    Zhang L; Zhao Y; Guan H; Zhang D
    Cancer Biomark; 2022; 34(3):443-457. PubMed ID: 35275521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosomal lncRNA HMMR-AS1 mediates macrophage polarization through miR-147a/ARID3A axis under hypoxia and affects the progression of hepatocellular carcinoma.
    Wang X; Zhou Y; Dong K; Zhang H; Gong J; Wang S
    Environ Toxicol; 2022 Jun; 37(6):1357-1372. PubMed ID: 35179300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA SNHG1 promotes cell progression and metastasis via sponging miR-377-3p in hepatocellular carcinoma.
    Qu A; Yang Q
    Neoplasma; 2020 May; 67(3):557-566. PubMed ID: 32122143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exosome-mediated transfer of circRNA563 promoting hepatocellular carcinoma by targeting the microRNA148a-3p/metal-regulatory transcription factor-1 pathway.
    Lyu ZZ; Li M; Yang MY; Han MH; Yang Z
    World J Gastroenterol; 2023 Dec; 29(46):6060-6075. PubMed ID: 38130740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing of hsa_circ_0101145 reverses the epithelial-mesenchymal transition in hepatocellular carcinoma via regulation of the miR-548c-3p/LAMC2 axis.
    Jin J; Liu H; Jin M; Li W; Xu H; Wei F
    Aging (Albany NY); 2020 Jun; 12(12):11623-11635. PubMed ID: 32554866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma.
    Liu Z; Wang Y; Wang L; Yao B; Sun L; Liu R; Chen T; Niu Y; Tu K; Liu Q
    J Exp Clin Cancer Res; 2019 May; 38(1):194. PubMed ID: 31088485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.